Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii

@article{Fournier2006ComparativeGO,
  title={Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii},
  author={Pierre-Edouard Fournier and David Vallenet and Val{\'e}rie Barbe and St{\'e}phane Audic and Hiroyuki Ogata and Laurent Poirel and Herv{\'e} M. Richet and Catherine Robert and Sophie Mangenot and Chantal Abergel and Patrice Nordmann and Jean Weissenbach and Didier Raoult and Jean-Michel Claverie},
  journal={PLoS Genetics},
  year={2006},
  volume={2}
}
Acinetobacter baumannii is a species of nonfermentative gram-negative bacteria commonly found in water and soil. This organism was susceptible to most antibiotics in the 1970s. It has now become a major cause of hospital-acquired infections worldwide due to its remarkable propensity to rapidly acquire resistance determinants to a wide range of antibacterial agents. Here we use a comparative genomic approach to identify the complete repertoire of resistance genes exhibited by the multidrug… Expand
Genetic basis of multidrug resistance in Acinetobacter baumannii
Acinetobacter baumannii has emerged as a significant bacterial pathogen pre-eminently associated with hospital-acquired infections. Strains of this species may currently exhibit resistance to nearlyExpand
Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
TLDR
Four hundred seventy-five genes are shared among all six clinical isolates but absent from the related environmental species Acinetobacter baylyi ADP1 and suggest physiological features of A. baumannii that are related to adaptation for growth in association with humans. Expand
The rise of carbapenem-resistant Acinetobacter baumannii.
TLDR
Colistin is now considered to be the final drug capable of treating infections caused by carbapenem-resistant A. baumannii; however, strains are now being isolated that are resistant to this antibiotic as well. Expand
Interspecies DNA acquisition by a naturally competent Acinetobacter baumannii strain
TLDR
It is shown that at least for certain pathogens the propagation of resistance genes occurs by alternative HGT mechanisms which in the past have been unappreciated, and transformation also plays a major role in the acquisition of antibiotic resistance determinants. Expand
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
  • M. Kempf, J. Rolain
  • Biology, Medicine
  • International journal of antimicrobial agents
  • 2012
TLDR
Current knowledge about A. baumannii, including biological and epidemiological aspects as well as resistance to antibiotics and antibiotic therapy, are reviewed in this article, in addition to therapeutic recommendations. Expand
Carbapenem-resistant Acinetobacter baumannii in Taiwan
TLDR
The rapid emergence and increase of imipenem resistance in A. baumannii in different areas of Taiwan is contributed to by a variety of mechanisms, and the finding of different resistant gene determinants could not explain the phenotypic variation in drug susceptibility. Expand
Characterization of Extremely Drug-Resistant and Hypervirulent Acinetobacter baumannii AB030
TLDR
Comparison genomics was used to understand the mechanisms of antibiotic resistance and virulence in AB030, an extremely drug-resistant and hypervirulent strain of A. baumannii that is a representative of a recently emerged lineage of the organism. Expand
A comparative study of class 1 integrons in Acinetobacter baumannii.
TLDR
The data suggest that the gain of class 1 integrons in A. baumannii strains may have started before the antibiotic era, and that the resistance genes included in integrons are horizontally transferred across all the A. BaumannII genomes. Expand
GENOMIC ANALYSES OF A POLYMYXIN-RESISTANT STRAIN OF CLINICAL ACINETOBACTER BAUMANNII
Acinetobacter baumannii, a Gram-negative bacterium, is a notorious nosocomial pathogen. It is innately resistant to almost all antimicrobial agents except polymyxin, the last drug of choice forExpand
Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art
TLDR
The intrinsic and acquired resistance mechanisms of A. baumannii are presented here, with special focus on β-lactam resistance, and the most up-to-date techniques for identification, including phenotypical and molecular tests, and screening of those emerging resistance traits are highlighted. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 79 REFERENCES
Transposon-mediated multiple antibiotic resistance in Acinetobacter strains
TLDR
It is suggested that a plasmid resistant to multiple antibiotics was transferred from the hospital flora into Acinetobacter sp. Expand
Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina.
  • S. Brown, H. Young, S. Amyes
  • Biology, Medicine
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2005
TLDR
OXA-51 is the first of a new subgroup of carbapenemases to emerge in multiresistant clinical isolates of A. baumannii, and was found to have < 63% amino-acid identity with subgroups 1 and 2, but displayed the highest affinity for imipenem. Expand
Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting.
TLDR
Plasmid DNA analysis proved to be useful in epidemiological typing of A baumannii strains and may serve as a complementary typing system to traditional epidemiological methods. Expand
Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes.
TLDR
Production of the VIM-2 enzyme presents an emerging threat of carbapenem resistance among Acinetobacter spp. Expand
Molecular Epidemiology of Sequential Outbreaks of Acinetobacter baumannii in an Intensive Care Unit Shows the Emergence of Carbapenem Resistance
TLDR
Class 1 integrons carrying antimicrobial resistance genes and blaIMP allele in A. baumannii epidemic strains correlated with the high use rates of broad-spectrum cephalosporins, carbapenems, and aminoglycosides in the ICU during the study period. Expand
Characterization of a Nosocomial Outbreak Caused by a Multiresistant Acinetobacter baumannii Strain with a Carbapenem-Hydrolyzing Enzyme: High-Level Carbapenem Resistance inA. baumannii Is Not Due Solely to the Presence of β-Lactamases
TLDR
The molecular characterization of a nosocomial outbreak caused by one multiresistant A. baumannii epidemic strain that harbors a carbapenem-hydrolyzing enzyme is reported here and shows that the outbreak was caused by a single IMRAB strain (genotype A). Expand
Outbreak of Extended-Spectrum β-Lactamase VEB-1-Producing Isolates of Acinetobacter baumannii in a French Hospital
TLDR
This report underlines the difficulty of the identification of ESBLs in A. baumannii and describes the VEB-1-producing strains as a source of an outbreak occurring outside Southeast Asia. Expand
Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii.
TLDR
The data indicate horizontal transfer of tetracycline resistance genes between A. baumannii and other genera sharing the same ecological niches. Expand
Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of Acinetobacter baumannii.
TLDR
It is confirmed that substitution of Ser-83 in GyrA is sufficient to confer ciprofloxacin MICs of ≥4 mg/L, and in agreement with other studs, this is consistent with the suggestion that resistance to fluoroquinolones could be a risk factor for epidemic behaviour in A. baumannii. Expand
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
TLDR
It is proposed that the size and complexity of the P. aeruginosa genome reflect an evolutionary adaptation permitting it to thrive in diverse environments and resist the effects of a variety of antimicrobial substances. Expand
...
1
2
3
4
5
...